Home › Funds › Chescapmanager LLC › CGTX
Chescapmanager LLC position in CGTX
COGNITION THERAPEUTICS INC · Health Care
Chescapmanager LLC reported holding 997,029 shares of CGTX (COGNITION THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$957K, representing 0.16% of its reported portfolio and ranking #22 among its reported holdings. Chescapmanager LLC has disclosed CGTX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Chescapmanager LLC's CGTX position evolved
Chescapmanager LLC first disclosed a stake in CGTX in Q2 2025 at 503,259 shares (US$156K). The position peaked in Q3 2025 at 997,029 shares, worth US$1.3M. Across 6 filings, Chescapmanager LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 997,029 shares valued at US$957K. Notable position changes include a 98% increase in Q3 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 503.26K | $155.91K | New |
| Q3 2025 | 997.03K | $1.35M | Add |
| Q4 2025 | 997.03K | $1.35M | Hold |
| Q1 2026 | 997.03K | $757.24K | Hold |
| Q2 2026 | 997.03K | $1.15M | Hold |
| Q3 2026 | 997.03K | $957.15K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CGTX and 13F data
CGTX (COGNITION THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in CGTX — the largest reported positions include BIOS Capital Management, LP (US$5.76B), Dauntless Investment Group, LLC (US$427K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CGTX
- BIOS Capital Management, LP 6.00M sh · $5.76B · Q3 2026
- Dauntless Investment Group, LLC 371.70K sh · $427.46K · Q2 2026
More on Chescapmanager LLC
FAQ
How long has Chescapmanager LLC held CGTX?
Chescapmanager LLC has disclosed CGTX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Chescapmanager LLC's current position in CGTX?
As of Q3 2026, Chescapmanager LLC holds 997.03K shares of CGTX (COGNITION THERAPEUTICS INC), valued at $957.15K, representing 0.16% of its reported portfolio and ranking #22.
Has Chescapmanager LLC been buying or selling CGTX?
In the latest 13F filing (Q3 2026), Chescapmanager LLC held unchanged its position in CGTX. The position peaked in Q3 2025 at 997.03K shares.
Which other funds hold CGTX?
Other major institutional holders of CGTX include BIOS Capital Management, LP, Dauntless Investment Group, LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.